Therefore, it is probable that partial CPT1b repression protects mice from HFD-induced insulin resistance by attenuating HFD-induced upregulation of fatty acid oxidation and upregulating glucose oxidation in skeletal muscle. The gene discussed is CPT1B; the disease is Insulin resistance.